The genetics of cognitive impairment in schizophrenia: A phenomic perspective

Trends in Cognitive Sciences

Volumn 15, Issue 9, 2011, Pages 428-435

  Bilder, Robert M ^a   Howe, Andrew ^b   Novak, Nic ^c   Sabb, Fred W ^a   Parker, D Stott ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COGNITIVE IMPAIRMENT; COLLABORATIVE KNOWLEDGE; GENETIC VARIANTS; KNOWLEDGE BASE; META ANALYSIS;

DISEASES;

APOLIPOPROTEIN E; SEROTONIN 2A RECEPTOR;

COGNITIVE DEFECT; ENDOPHENOTYPE; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC VARIABILITY; GENETICS; HERITABILITY; HUMAN; INTERNET; NONHUMAN; PHENOTYPE; REVIEW; SCHIZOPHRENIA;

COGNITION DISORDERS; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHENOTYPE; SCHIZOPHRENIA;

EID: 80051918472     PISSN: 13646613     EISSN: 1879307X     Source Type: Journal    
DOI: 10.1016/j.tics.2011.07.002     Document Type: Review

References (43)

1. Kraepelin E. Dementia Praecox and Paraphrenia 1919, E and S Livingstone.
2. Purcell S.M., et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 2009, 460:748-752.
3. Rzhetsky A., et al. Probing genetic overlap among complex human phenotypes. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:11694-11699.
4. Greenwood T.A., et al. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2011, 10.1176/appi.ajp.2011.10050723.
5. Bilder R.M. The neuropsychology of schizophrenia circa 2009. Neuropsychol. Rev. 2009, 19:277-279.
6. Bilder R.M., et al. Phenomics: the systematic study of phenotypes on a genome-wide scale. Neuroscience 2009, 164:30-42.
7. Sabb F.W., et al. A collaborative knowledge base for cognitive phenomics. Mol. Psychiatry 2008, 13:350-360.
8. Greenwood T.A., et al. Initial heritability analyses of endophenotypic measures for schizophrenia: the consortium on the genetics of schizophrenia. Arch. Gen. Psychiatry 2007, 64:1242-1250.
9. Plomin R., et al. Generalist genes: genetic links between brain, mind, and education. Mind Brain Educ. 2007, 1:11-19.
10. Haworth C.M., et al. Generalist genes and high cognitive abilities. Behav. Genet. 2009, 39:437-445.
11. Plomin R., Haworth C.M. Genetics of high cognitive abilities. Behav. Genet. 2009, 39:347-349.
12. Toulopoulou T., et al. Substantial genetic overlap between neurocognition and schizophrenia: genetic modeling in twin samples. Arch. Gen. Psychiatry 2007, 64:1348-1355.
13. Toulopoulou T., et al. Impaired intellect and memory: a missing link between genetic risk and schizophrenia?. Arch. Gen. Psychiatry 2010, 67:905-913.
14. Owens S.F., et al. Genetic overlap between episodic memory deficits and schizophrenia: results from the Maudsley Twin Study. Psychol. Med. 2011, 41:521-532.
15. Flint J., Munafo M.R. The endophenotype concept in psychiatric genetics. Psychol. Med. 2007, 37:163-180.
16. Butcher L.M., et al. Generalist genes and cognitive neuroscience. Curr. Opin. Neurobiol. 2006, 16:145-151.
17. Heulens I., Kooy F. Fragile X syndrome: from gene discovery to therapy. Front. Biosci. 2011, 16:1211-1232.
18. Silva A.J., et al. Molecular and cellular approaches to memory allocation in neural circuits. Science 2009, 326:391-395.
19. Lee Y.S., Silva A.J. The molecular and cellular biology of enhanced cognition. Nat. Rev. 2009, 10:126-140.
20. Visscher P.M. Sizing up human height variation. Nat. Genet. 2008, 40:489-490.
21. Manolio T.A., et al. Finding the missing heritability of complex diseases. Nature 2009, 461:747-753.
22. Need A.C., et al. A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. Hum. Mol. Genet. 2009, 18:4650-4661.
23. Sabb F.W., et al. Challenges in phenotype definition in the whole-genome era: multivariate models of memory and intelligence. Neuroscience 2009, 164:88-107.
24. Tam G.W., et al. Confirmed rare copy number variants implicate novel genes in schizophrenia. Biochem. Soc. Trans. 2010, 38:445-451.
25. Allen N.C., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
26. Ioannidis J.P., et al. Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 2008, 37:120-132.
27. Helkala E.L., et al. Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study. Neurosci. Lett. 1996, 204:177-180.
28. Helkala E.L., et al. The association of apolipoprotein E polymorphism with memory: a population based study. Neurosci. Lett. 1995, 191:141-144.
29. Yarkoni T., et al. Cognitive neuroscience 2.0: building a cumulative science of human brain function. Trends Cogn. Sci. 2010, 14:489-496.
30. Bilder R.M. Neuropsychology 3.0: evidence-based science and practice. J. Int. Neuropsychol. Soc. 2011, 17:7-13.
31. Bilder R.M., et al. Cognitive ontologies for neuropsychiatric phenomics research. Cogn. Neuropsychiatry 2009, 14:419-450.
32. Insel T.R., Cuthbert B.N. Endophenotypes: bridging genomic complexity and disorder heterogeneity. Biol. Psychiatry 2009, 66:988-989.
33. Insel T., et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am. J. Psychiatry 2010, 167:748-751.
34. Stranger B.E., et al. Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 2007, 315:848.
35. Gottesman I.I., Shields J. Genetic theorizing and schizophrenia. Br. J. Psychiatry 1973, 122:15-30.
36. Gottesman I.I., Gould T.D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 2003, 160:636-645.
37. Allott K., et al. Cognition at illness onset as a predictor of later functional outcome in early psychosis: systematic review and methodological critique. Schizophr. Res. 2011, 125:221-235.
38. Bora E., et al. Cognitive functioning in schizophrenia, schizoaffective disorder and affective psychoses: meta-analytic study. Br. J. Psychiatry 2009, 195:475-482.
39. Mesholam-Gately R.I., et al. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009, 23:315-336.
40. Keefe R.S., et al. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial. Arch. Gen. Psychiatry 2007, 64:633-647.
41. Hill S.K., et al. Effect of second-generation antipsychotics on cognition: current issues and future challenges. Expert Rev. Neurotherapeutics 2010, 10:43-57.
42. Cacabelos R., et al. Pharmacogenomics of antipsychotics efficacy for schizophrenia. Psychiatry Clin. Neurosci. 2011, 65:3-19.
43. Krystal J.H., et al. Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug Discov. Today 2009, 14:690-697.